Recent health news highlights include global bird flu restrictions impacting Brazilian chicken exports, advancements in ...

Caris Life Sciences shares ended trading at $28 per share on Wednesday, marking a 33% increase from its initial public offering (IPO) price of $21 per share.

Cancer-testing company raises $494 million in initial public offering.

Former California governor Arnold Schwarzenegger touted the "responsibility" of immigrants to follow the laws, give back to America and behave like guests during "The View." Strong winds broke loose a ...

Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering, the cancer diagnostic firm said on Tuesday, ...

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public ...

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.